Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 28, 2018; 24(4): 511-518
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.511
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.511
Table 3 Genotypes of NUDT15 and TPMT
| Patients | Exon1 | Exon 3 | TPMT |
| Group A (n = 3) | |||
| #1-#3 | c.52G > A (p.Val18Ile) | Wild | Wild |
| Group B (n = 3) | |||
| #4-#6 | c.36_37insGGAGTC (p.Val18 Val19insGlyVal) | c.415C>T (p.Arg139Cys) | Wild |
| Group C (n = 18) | |||
| #7-#24 | Wild | c.415C>T (p.Arg139Cys) | Wild |
| Group D (n = 72) | |||
| #25-#96 | Wild | Wild | Wild |
- Citation: Kojima Y, Hirotsu Y, Omata W, Sugimori M, Takaoka S, Ashizawa H, Nakagomi K, Yoshimura D, Hosoda K, Suzuki Y, Mochizuki H, Omata M. Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines. World J Gastroenterol 2018; 24(4): 511-518
- URL: https://www.wjgnet.com/1007-9327/full/v24/i4/511.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i4.511